Jennifer Champagne, PharmD, RPh, BCPS

Jennifer Champagne is a pharmacy department manager at a midsized community hospital. Jennifer has over 10 years of experience with inpatient hospital care in addition to experience in the retail setting. Jennifer is a Board-Certified Pharmacotherapy Specialist. Her primary focus of care has been internal medicine.

All articles by Jennifer Champagne, PharmD, RPh, BCPS

Liver

Nucleos(t)ide Analog Withdrawal in Patients With Chronic Hepatitis B

Jennifer Champagne, PharmD, RPh, BCPS

January 20, 2022

Investigators assessed virological, biochemical, and clinical outcomes following cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B.

Pediatric gastroenterology

Safe and Tolerable Novel Anti-Regurgitation Formula

Jennifer Champagne, PharmD, RPh, BCPS

January 11, 2022

Investigators assessed the safety and tolerability of a novel anti-regurgitation formula for use in infants.

Stomach Disorders

Safety and Efficacy of Ramucirumab Plus Paclitaxel in Asian Patients With Advanced Gastric Cancer

Jennifer Champagne, PharmD, RPh, BCPS

December 29, 2021

In the continuation of a previously published study, investigators evaluated the safety and efficacy of ramucirumab plus paclitaxel for treatment of advanced gastric cancer.

AIBD 2021

Proton Pump Inhibitors Impact Outcomes for Patients With Inflammatory Bowel Disease Receiving Infliximab

Jennifer Champagne, PharmD, RPh, BCPS

December 17, 2021

Investigators assessed whether PPI therapy is associated with decreased remission rates and increased hospitalizations among patients with IBD receiving infliximab.

AIBD 2021

Treatment of Moderate to Severe Ulcerative Colitis With Ozanimod

Jennifer Champagne, PharmD, RPh, BCPS

December 16, 2021

Investigators reported long-term findings on the efficacy of treatment with ozanimod vs placebo in North American patients with moderate to severe ulcerative colitis.

Liver

Cardiovascular Disease Risk Associated With Nonalcoholic Fatty Liver Disease

Jennifer Champagne, PharmD, RPh, BCPS

December 8, 2021

Investigators assessed the relationship between nonalcoholic fatty liver disease and risk for both fatal and nonfatal cardiovascular disease events.

Liver

Increased Risk for Cardiovascular Events in Patients With Nonalcoholic Fatty Liver Disease

Jennifer Champagne, PharmD, RPh, BCPS

November 30, 2021

Investigators assessed the incidence of major adverse cardiovascular events in patients with histologically-confirmed nonalcoholic fatty liver disease.

Liver

Outcomes Improved by Carvedilol in Patients With Cirrhosis and Ascites

Jennifer Champagne, PharmD, RPh, BCPS

November 23, 2021

Investigators assessed the long-term outcomes of patients with cirrhosis and ascites switched from treatment with propranolol to carvedilol.

Other bowel disorders

Impact of Cost Sharing on Presentation in Acute Appendicitis or Diverticulitis

Jennifer Champagne, PharmD, RPh, BCPS

November 18, 2021

Investigators assessed the association between cost sharing and likelihood of uncomplicated presentation and surgical management of acute appendicitis or diverticulitis.